NCT01774708 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Johnson TM, Capezuti E, Whalen T, Vandenberg AE, Taylor T, Cohen M
Predicting resident bed exits in long-term care. Journal of the American Geriatrics Society. 2016; 64(S1): S183.
Vandenberg AE, van Beijnum BJ, Overdevest VGP, Capezuti E, Johnson TM 2nd
US and Dutch nurse experiences with fall prevention technology within nursing home environment and workflow: A qualitative study. Geriatr Nurs. 2017 Jul - Aug;38(4):276-282. doi: 10.1016/j.gerinurse.2016.11.005. Epub 2016 Dec 10.

Predict Near Future Initiation of Bed Exit to Prompt Effective Intervention to Avoid Nighttime Falls With Pattern-recognition Algorithms Using Unobtrusive Monitoring of Movement and Vital Signs

Details for clinical trial NCT01774708

Clinical trial NCT01774708 - References